WGU D027 EXAM QUESTIONS AND
ANSWERS GRADED A+ 2025/2026
Donepezil/Aricept - ANS Mild to moderate Alzheimer
Rivastigmine/Exelon - ANS mild to moderate Alzheimer's
Galantamine/Razadyne - ANS mild to moderate Alzheimer's
Memantine/Namenda - ANS moderate to severe alzheimers
Donepezil + Memantine (Namzaric) - ANS Moderate to severe Alzheimer - approved by the
FDA
Cholinesterase inhibitors - ANS Treat sx related to memory, thinking, language, judgment and
other though processes.
Ataxia symptoms - ANS Mimic those of being drunk: slurred speech, stumbling, falling, and
incoordination.
Cerebellum function - ANS Balance and coordination
Celiac Disease - ANS malabsorption syndrome caused by an immune reaction to gluten
1 @COPYRIGHT 2025/2026 ALLRIGHTS RESERVED.
, Celiac disease genetic predisposition - ANS HLA-DQ2 and HLA-DQ8
Celiac diagnostic methods - ANS IgA antibodies and HLA-DQ2 or HLA-DQ8; duodenal biopsy
Celiac treatment - ANS Gluten-free diet, steroids or immunosuppressants
Crohn's disease - ANS a chronic autoimmune disorder that can occur anywhere in the
digestive tract; however, it is most often found in the ileum and in the colon
Crohns appearance under microscope - ANS Cobblestoning
Crohns risk - ANS People with atopic dermatitis and eczema
Lab test for Crohns - ANS Anti-Saccharamyces cerevisiae (ASCA)
Lab test for ulcerative colitis - ANS perinuclear anti-neutrophil cytoplasmic antibody (pANCA)
1st Medication tx for Crohns - ANS Aminosalicylate (sulfasalazine or mesalamine)
Most common color troubles with color blindness - ANS Differentiating between red and
green
Chronic bronchitis - ANS inflammation of the bronchi persisting over a long time
Emphysema - ANS a condition in which the air sacs of the lungs are damaged and enlarged,
causing breathlessness.
COPD 1st line treatment - ANS short-acting bronchodilator inhaler
2 @COPYRIGHT 2025/2026 ALLRIGHTS RESERVED.
ANSWERS GRADED A+ 2025/2026
Donepezil/Aricept - ANS Mild to moderate Alzheimer
Rivastigmine/Exelon - ANS mild to moderate Alzheimer's
Galantamine/Razadyne - ANS mild to moderate Alzheimer's
Memantine/Namenda - ANS moderate to severe alzheimers
Donepezil + Memantine (Namzaric) - ANS Moderate to severe Alzheimer - approved by the
FDA
Cholinesterase inhibitors - ANS Treat sx related to memory, thinking, language, judgment and
other though processes.
Ataxia symptoms - ANS Mimic those of being drunk: slurred speech, stumbling, falling, and
incoordination.
Cerebellum function - ANS Balance and coordination
Celiac Disease - ANS malabsorption syndrome caused by an immune reaction to gluten
1 @COPYRIGHT 2025/2026 ALLRIGHTS RESERVED.
, Celiac disease genetic predisposition - ANS HLA-DQ2 and HLA-DQ8
Celiac diagnostic methods - ANS IgA antibodies and HLA-DQ2 or HLA-DQ8; duodenal biopsy
Celiac treatment - ANS Gluten-free diet, steroids or immunosuppressants
Crohn's disease - ANS a chronic autoimmune disorder that can occur anywhere in the
digestive tract; however, it is most often found in the ileum and in the colon
Crohns appearance under microscope - ANS Cobblestoning
Crohns risk - ANS People with atopic dermatitis and eczema
Lab test for Crohns - ANS Anti-Saccharamyces cerevisiae (ASCA)
Lab test for ulcerative colitis - ANS perinuclear anti-neutrophil cytoplasmic antibody (pANCA)
1st Medication tx for Crohns - ANS Aminosalicylate (sulfasalazine or mesalamine)
Most common color troubles with color blindness - ANS Differentiating between red and
green
Chronic bronchitis - ANS inflammation of the bronchi persisting over a long time
Emphysema - ANS a condition in which the air sacs of the lungs are damaged and enlarged,
causing breathlessness.
COPD 1st line treatment - ANS short-acting bronchodilator inhaler
2 @COPYRIGHT 2025/2026 ALLRIGHTS RESERVED.
